4
Changes in Ownership
KYNTRA BIO, INC. Filed Acc 0001209191-19-061939
SVP, Finance and CFO sold 59,456 shares at an average $45.67 ($2,715,517)
- SVP, Finance and CFO acquired 56,254 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Cotroneo Pat · SVP, Finance and CFO
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-12-20 | Exercise or conversion : show line 1 in the form | +18,000 | $3.50 | $63,000 | 271,788 | D |
| 2019-12-20 | Exercise or conversion : show line 2 in the form | +21,000 | $5.95 | $124,950 | 292,788 | D |
| 2019-12-20 | Exercise or conversion : show line 3 in the form | +17,254 | $14.58 | $251,477 | 310,042 | D |
| 2019-12-20 | Sale : show line 4 in the form | −46,727 | $45.51 | $2,126,546 | 263,315 | D |
| 2019-12-20 | Sale : show line 5 in the form | −12,729 | $46.27 | $588,971 | 250,586 | D |
| Open-market sales · 59,456 sh · avg $45.67 · $2,715,517 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2019-12-20 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −18,000 | $3.50 | 2021-06-07 | 18,000 | 0 | D |
| 2019-12-20 | Exercise or conversion : show line 7 in the form Stock Optin (Right to Buy) | −21,000 | $5.95 | 2022-06-27 | 21,000 | 0 | D |
| 2019-12-20 | Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) | −17,254 | $14.58 | 2024-03-19 | 17,254 | 0 | D |
Loading xslF345X03/doc4.xml…